---
document_datetime: 2026-01-26 15:26:49
document_pages: 5
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/exelon-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: exelon-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 7.7609019
conversion_datetime: 2026-02-01 20:30:04.164642
docling_version:
  docling-serve: 1.11.0
  docling-jobkit: 1.9.1
  docling: 2.71.0
  docling-core: 2.62.0
  docling-ibm-models: 3.11.0
  docling-parse: 4.7.3
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Exelon

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency' s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessmenthistory'section.Forthe completeproduct lifecycleprocedures,you mayneedtoalsorefertoEPAR-Proceduralsteps taken andscientific informationafterauthorisation(archive).

| Applicationnumber   | Scope                       | Opinion/ Notification 1 issued on   | Commission Decision IssuedÂ²/ amendedon   | Product Information affected3   | Summary   |
|---------------------|-----------------------------|-------------------------------------|------------------------------------------|---------------------------------|-----------|
| Variation type IA / | A.ADMINISTRATIVECHANGES-A.7 | 23/01/2026                          |                                          | SmPC,Annex                      |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000323550                    | Deletion ofmanufacturingsitesfor an active substance, intermediate or finished product, packaging site, manufacturer responsible for batch release, site where batch control takes place,orsupplierofastartingmaterial, reagent orexcipient(when mentioned in the dossier)*- Accepted                                                                                                                                                                                                                                                                                                                                                                                                             |            | II, Labelling and PL   |
|--------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------------------|
| Variation typeIB / EMA/VR/0000297093 | This was an application for a group of variations. B.III.1.bEuropeanPharmacopoeialTSE Certificateofsuitabilityfor an active substance/startingmaterial/reagent/ intermediate/or excipient-B.II1.1.b.3 Updatedcertificatefrom analready approvedmanufacturer-Accepted B.II.d.2 Change in test procedure for the finished product - B.II.d.2.a Minor changes to an approved testprocedure-Accepted B.II.d.2 Change in test procedure for the finished product-B.II.d.2.z Other changes- Accepted B.III.1.bEuropeanPharmacopoeial TSE Certificate ofsuitabilityfor an active substance/starting material/reagent/ intermediate/or excipient-B.III.1.b.2 New certificateforastartingmaterial/reagent/ | 09/12/2025 |                        |

<div style=\"page-break-after: always\"></div>

| already approved manufacturer- Accepted  B.III.1.bEuropeanPharmacopoeial TSE Certificate ofsuitabilityfor an active substance/startingmaterial/reagent/ intermediate/orexcipient-B.Ill.1.b.2New certificateforastartingmaterial/reagent/ intermediate/or excipient from a new or an already approved manufacturer- Accepted  B.Ill.1.bEuropeanPharmacopoeialTSE Certificateofsuitabilityfor anactive substance/startingmaterial/reagent/ intermediate/or excipient-B.1I1.1.b.4 Deletionofcertificates(incasemultiple certificates exist per material) -Accepted  B.III.1.bEuropeanPharmacopoeial TSE Certificate ofsuitabilityfor an active substance/startingmaterial/reagent/ intermediate/or excipient - B.II1.1.b.4 Deletion of certificates (in case multiple certificates exist per material) - Accepted  B.Ill.1.bEuropeanPharmacopoeialTSE Certificate ofsuitabilityfor an active substance/startingmaterial/reagent/ intermediate/or excipient-B.1I1.1.b.4 Deletion of certificates(in casemultiple certificates exist per material) - Accepted  B.IIl.1.bEuropeanPharmacopoeial TSE   |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

|                                       | Certificate ofsuitabilityfor an active substance/starting material/reagent/ intermediate/or excipient - B.II1.1.b.4 Deletion of certificates (in case multiple certificates exist per material)-Accepted B.IIl.1.bEuropeanPharmacopoeial TSE Certificateofsuitabilityfor an active substance/starting material/reagent/ intermediate/or excipient-B.IIl.1.b.4 Deletion of certificates(in case multiple certificates exist per material)-Accepted   |            |     |    |
|---------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|----|
| Variation type IA / EMA/VR/0000291442 | This was an application for a group of variations. B.II.d.1 Change in the specification parameters and/or limits of the finished product - B.II.d.1.a Tightening of specification limits - Accepted B.II.d.1 Change in the specification parameters and/or limits of the finished product - B.1II.d.1.a Tightening of specification limits - Accepted                                                                                               | 11/08/2025 | N/A |    |
| Article 61(3) / EMA/N/0000263584      | -Notification acc.Article 61(3)-Accepted Update of the product information to align the ADRs listed in sections'4.Possible side effects'ofthepackageleafletwithsection                                                                                                                                                                                                                                                                              | 11/04/2025 |     | PL |

<div style=\"page-break-after: always\"></div>

|                                       | 4.8 of the SmPC and to introduce an updated image for Exelon transdermal patch (EU/1/98/066/019-050) under'Where to apply your Exelon transdermal patch' in section'3.How touseExelon'ofthe package leaflet.                                                                                                                                                                                                                                                                                                                                                                                         |            |     |
|---------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| Variation type IB / EMA/VR/0000245362 | This was an application for a group of variations. B.1.b.1 Change in the specification parameters and/or limits of an active substance,startingmaterial/intermediate/ reagent used in the manufacturing process of the active substance-B.I.b.1.c Addition of anewspecificationparametertothe specificationwith its corresponding test method-Accepted B.I.a.3 Change in batch size (including batch sizeranges)of active substance or intermediate used in the manufacturing process of the active substance - B.I.a.3.a Upto10-foldincreasecomparedtothe originally approved batch size - Accepted | 06/03/2025 | N/A |